Review of MIS-C Clinical Protocols and Diagnostic Pathways: Towards a Consensus Algorithm

Ashley Tritt1,2, Ikram-Nour Abda3, Nagib Dahdah4

  • 1Faculty of Medicine, Université de Montréal, Montreal, Québec, Canada.

Insights

Pediatric centers rapidly developed clinical pathways for multisystem inflammatory syndrome in children (MIS-C) during the COVID-19 pandemic. While initial investigations showed agreement, further assessment of these evolving MIS-C protocols is needed.

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Pathway Development
  • Pandemic Response

Background:

  • The COVID-19 pandemic spurred the creation of institutional clinical pathways for multisystem inflammatory syndrome in children (MIS-C).
  • These pathways were largely based on expert opinion due to the novel nature of MIS-C.
  • North American pediatric centers adapted their approaches to diagnosing and managing MIS-C.

Purpose of the Study:

  • To assess how North American pediatric centers adapted to MIS-C during the pandemic.
  • To analyze the agreement among institutional algorithms for tiered clinical investigations in MIS-C patients.
  • To propose a composite algorithm based on common practices.

Main Methods:

  • Evaluation of MIS-C diagnostic algorithms from 50 tertiary centers in the US and Canada (May 2020-December 2021).
  • Data obtained through online searches and professional networks.
  • Descriptive statistics were employed to analyze the collected algorithms.

Main Results:

  • All pathways utilized a tiered investigation approach, with most mandating COVID-19 PCR testing.
  • Basic biochemical workups were universal, while specialized tests like cardiac biomarkers were secondary.
  • Significant variation existed in the tier distribution for urine studies, blood cultures, chest radiography, and COVID-19 serology.

Conclusions:

  • Pediatric institutions demonstrated rapid adaptation and standardization of MIS-C evaluation amidst evolving knowledge.
  • Most pathways converged on initial basic screening and secondary cardiac investigations.
  • Comparative assessment of the efficacy and superiority of these hastily developed MIS-C protocols is warranted.
Abstract

Related Concept Videos